Illumina Reports Its Q1 Results on Thursday: 3 Things You Can Expect

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 23, 2019 at 10:12 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via Illumina's (NASDAQ: ILMN) planned acquisition of Pacific Biosciences of California ("PacBio") hit a snag recently with the decision by regulators in the United Kingdom to investigate the transaction. You can count on this being a major topic of discussion when Illumina provides its first-quarter update on Thursday, April 25, after the market closes.

    article source